The Latest “Buzz on the Street” Show: Featuring Pressure Biosciences Inc. (OTCQB: PBIO) Coverage

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Pressure BioSciences Makes CBD Oil Water Soluble, Offering Solution to CBD Absorption Issue in Food & Beverages” and “Scientific Analyses Confirm Important Benefits from Processing CBD Oil with Pressure BioSciences’ Proprietary Ultra Shear Technology Platform”

Pressure BioSciences, Inc. (OTCQB: PBIO) on the 13th, released a short video demonstrating the Company’s proprietary Ultra Shear Technology (USTTM) platform and its ability to create extremely small, nanometer-scale oil droplets that effectively dissolve in water (nanoemulsions) to provide optimized bioavailability for absorption.

Pressure BioSciences, Inc. announced that analytical testing on hemp-derived CBD oil processed via PBI’s Ultra Shear Technology™ platform has confirmed that UST processing uniquely achieves the challenging criteria for creating highly-effective “nanoemulsions” of CBD oil in water, without loss or modification of CBD throughout the entire UST process.

Pressure BioSciences, Inc. is a leader in the development & sale of innovative, enabling, pressure-based platform solutions for the worldwide life sciences industry. Their products/services are based on three patented, pressure-enhanced platforms: Pressure Cycling Technology, Pressure Enabled Protein Manufacturing Technology, and Ultra Shear Technology.

In the past few decades, medical institutions had begun to use cannabis a form of treatment, as a result of its multifarious therapeutic effects. Researchers have conducted years of studies in order to understand the plant and its effects further. Positive results have thus allowed the integration of cannabis into medical facilities, but it also helped propel the global legalization efforts. The active components in cannabis, THC and CBD, are linked to possessing beneficial effects on the body, which make them popular options for treatment. Currently, cannabis is predominately being used to treat mild to severe medical conditions such as chronic pain, cancer, epilepsy, and seizures. And according to data compiled by Acute Market Reports, the global medical marijuana market was valued at USD 13.9 Billion in 2017 and is expected to reach USD 57.58 Billion by 2026. Additionally, the market is projected to expand at a healthy CAGR of 17.1% throughout the forecast period from 2018 to 2026. Dispensaries are expected to flourish during the period because they offer a wide range of products, including remedies to treat pain even though medical institutions may look to use certain biotechnology or pharmaceutical manufacturers’ products to treat more severe conditions. With the rates of medical cases like cancer continually rising year over year, it is projected that the demand for medical cannabis will increase throughout the period as well.      

North America is the global leader in the medical cannabis industry, primarily due to its rising prevalence of cancer and proactive policies. Canada has fully legalized cannabis entirely, while the U.S. boasts just over 30 states that have adopted cannabis for medical use. The U.S. is the largest cannabis market globally despite not having legalized cannabis entirely on a federal scale. However, ongoing legalization efforts have made regulations regarding the plant much more lenient. Regulations have allowed manufacturers to produce cannabis not only in forms of flower, but also in different variations like capsules, tinctures, creams, and even oils. On the other hand, federal regulations regarding THC are still heavily enforced around theU.S. CBD, though, is completely legalized because of its non-psychoactive effects. “CBD can supplement a depleted ECS system by working to ease the unfriendly symptoms in the body with the goal to help the body achieve homeostasis, or balance. Just like our body produces calcium, and some people take calcium supplements, we can use CBD in the same way,” said Tisha Trautsch,  RN, BSN, who recently led a course on about the history, products and potential benefits of CBD, “This isn’t a cure, it’s a supplement. But it is very up-and-coming. It’s coming hard and it’s coming fast.” 

For more information, please visit: Pressure Biosciences, Inc.

For more corporate news on Pressure Biosciences Inc., check out the Buzz on the Street

About Buzz on the Street: One of FinancialBuzz.com’s latest corporate and financial news shows, covering the latest trending stock market news. Buzz on the Street looks to become a leader in corporate video news dissemination. Buzz on the Street is 100% original content, brought to you by Financial Buzz Media.

Sponsored Content Release. Click for Full Disclosure

 

5 Comments
  1. Jonathan Pazmino 3 weeks ago
    Reply

    I thought oil and water don’t mix? How would it make absorption easier?

    • Leon Fitzgerald 3 weeks ago
      Reply

      Is it safe to mix alcohol with #CBD? I plan to drink a lot but didn’t want to stop taking my faithful #CBDoil.

  2. Phil Wahba 3 weeks ago
    Reply

    CBD oil is gaining momentum in the health and wellness world in addition to the food and beverage industry

    • Katherine Chase 2 weeks ago
      Reply

      $PBIO has the technology to solve a big problem at a larger industry scale. The stock is up almost 100% since the second week of Feb.

      • Joseph Enriquez 2 weeks ago
        Reply

        does it provide cbd for pets or only for human consumption?

Leave a Comment

  • Sponsored Content Release

    FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

    Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the ‘Site’) is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For pressure biosciences, inc, financial and corporate news dissemination, FinancialBuzz.com has been compensated five thousand dollars by the company. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com will always disclose any compensation in securities or cash payments for financial news PR advertising. FinancialBuzz.com does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: http://www.financialbuzz.com.